Merck KGaA (MKKGY)
OTCMKTS
· Delayed Price · Currency is USD
27.29
-0.10 (-0.38%)
Apr 24, 2025, 1:44 PM EDT
Merck KGaA Revenue
In the year 2024, Merck KGaA had annual revenue of 21.16B EUR with 0.78% growth. Merck KGaA had revenue of 5.42B in the quarter ending December 31, 2024, with 3.69% growth.
Revenue
21.16B EUR
Revenue Growth
+0.78%
P/S Ratio
2.72
Revenue / Employee
358.45K EUR
Employees
59,020
Market Cap
59.60B USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 21.16B | 163.00M | 0.78% |
Dec 31, 2023 | 20.99B | -1.24B | -5.57% |
Dec 31, 2022 | 22.23B | 2.55B | 12.93% |
Dec 31, 2021 | 19.69B | 2.15B | 12.28% |
Dec 31, 2020 | 17.53B | 1.38B | 8.56% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
SS Innovations International | 20.65M |
Endo Inc. | 1.76B |
Veradigm | 588.02M |
Northwest Biotherapeutics | 1.38M |
Elite Pharmaceuticals | 70.00M |
Glass House Brands | 200.90M |
BioStem Technologies | 301.83M |
American Oncology Network | 1.76B |
Merck KGaA News
- 5 weeks ago - Merck KGaA: Still A Bit Too Expensive - Seeking Alpha
- 7 weeks ago - Merck KGaA (MKGAF) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Merck KGaA sees forex-adjusted earnings growth of up to 8% this year - Reuters
- 2 months ago - Merck KGaA to replace two executives with company veterans - Reuters
- 2 months ago - Exclusive: Germany's Merck KGaA in talks to buy US cancer biotech firm Springworks, sources say - Reuters
- 3 months ago - Merck KGaA says high asset prices call for prudent M&A approach - Reuters
- 3 months ago - Mirror Biologics Enters Clinical Collaboration with Merck KGaA, Darmstadt, Germany in Metastatic Colorectal Cancer - GlobeNewsWire
- 5 months ago - Merck KGaA (MKGAF) Q3 2024 Earnings Call Transcript - Seeking Alpha